Brett Newswanger

Geschäftsführer bei ClostraBio, Inc.

Health Technology

Aktive Beziehungen

Name	Geschlecht	Alter	Unternehmensverbindungen	Zusammenarbeit
Cathryn R. Nagler	M	-	ClostraBio, Inc. ClostraBio, Inc. BiotechnologyHealth Technology ClostraBio, Inc. develops microbiome-modulating therapeutics. It creates a drug that aims to prevent allergic reactions to food. The firm is dedicated to understanding and treating food allergies and other diseases of the immune system. The company was founded by Cathryn R. Nagler and Jeffrey A. Hubbell and is headquartered in Chicago, IL.	-
Jeffrey A. Hubbell	M	-	ClostraBio, Inc. ClostraBio, Inc. BiotechnologyHealth Technology ClostraBio, Inc. develops microbiome-modulating therapeutics. It creates a drug that aims to prevent allergic reactions to food. The firm is dedicated to understanding and treating food allergies and other diseases of the immune system. The company was founded by Cathryn R. Nagler and Jeffrey A. Hubbell and is headquartered in Chicago, IL.	-
John Flavin	M	55	ClostraBio, Inc. ClostraBio, Inc. BiotechnologyHealth Technology ClostraBio, Inc. develops microbiome-modulating therapeutics. It creates a drug that aims to prevent allergic reactions to food. The firm is dedicated to understanding and treating food allergies and other diseases of the immune system. The company was founded by Cathryn R. Nagler and Jeffrey A. Hubbell and is headquartered in Chicago, IL.	-
Ritu Shah	F	48	ClostraBio, Inc. ClostraBio, Inc. BiotechnologyHealth Technology ClostraBio, Inc. develops microbiome-modulating therapeutics. It creates a drug that aims to prevent allergic reactions to food. The firm is dedicated to understanding and treating food allergies and other diseases of the immune system. The company was founded by Cathryn R. Nagler and Jeffrey A. Hubbell and is headquartered in Chicago, IL.	1 Jahre